Jill M. Broadfoot
2011 - Vical
In 2011, Jill M. Broadfoot earned a total compensation of $775.2K as Senior Vice President, Chief Financial Officer and Secretary at Vical, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Option Awards | $202,750 |
| Salary | $304,000 |
| Stock Awards | $127,800 |
| Other | $618 |
| Total | $775,168 |
Broadfoot received $304K in salary, accounting for 39% of the total pay in 2011.
Broadfoot also received $140K in bonus, $202.8K in option awards, $127.8K in stock awards and $618 in other compensation.
Rankings
In 2011, Jill M. Broadfoot's compensation ranked 6,573rd out of 10,747 executives tracked by ExecPay. In other words, Broadfoot earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,573 out of 10,747 | 39th |
Division Manufacturing | 2,385 out of 3,960 | 40th |
Major group Chemicals And Allied Products | 557 out of 1,033 | 46th |
Industry group Drugs | 367 out of 781 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 57 out of 157 | 64th |
Source: SEC filing on April 10, 2013.
Broadfoot's colleagues
We found two more compensation records of executives who worked with Jill M. Broadfoot at Vical in 2011.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019